Brief communication on allele frequency of CYP3A4*22 in Indian population
Keywords:
CYP3A4*22, allele distribution, Cyp alleleAbstract
Cytochrome p450 3A4 polymorphism at CYP3A4*22 has become clinically significant due to its role in metabolizing various drugs. Therefore, in this study we established the frequency of CYP3A4*22 variant in Indian population. The allele frequency distribution was determined in 350 healthy subjects of Indian origin by Real time polymerase chain reaction method. We found that 97% of subjects has AA variant and 3% subjects has AG variant of CYP3A4*22. We did not find any homozygous minor allele AA variant. However, studies conducted in other population also did not show any homologous minor allele with exception to Belgium. The p-value of Hardy Weinberg equilibrium is observed as 0.9, which was calculated using the chi-square model. This study shows significant difference in the distribution of allelic variants of CYP3A4*22 among various ethnicities. Therefore, the study results may provide an insight in genotype distribution of the CYP3A4*22 in Indian population for further studies.
Downloads
References
Guengerich FP. Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol. 1999; 39:1-17. doi: 10.1146/annurev.pharmtox.39.1.1. PMID: 10331074.
Achour B, Barber J, Rostami-Hodjegan A. Expression of hepatic drug-metabolizing cytochrome p450 enzymes and their intercorrelations: a meta-analysis. Drug Metab Dispos. 2014 Aug; 42(8):1349-56. doi: 10.1124/dmd.114.058834. Epub 2014 May 30. PMID: 24879845.
Rodríguez-Antona C, Donato MT, Pareja E, Gómez-Lechón MJ, Castell JV. Cytochrome P-450 mRNA expression in human liver and its relationship with enzyme activity. Arch Biochem Biophys. 2001 Sep 15;393(2):308-15. doi: 10.1006/abbi.2001.2499. PMID: 11556818.
Westlind A, Löfberg L, Tindberg N, Andersson TB, Ingelman-Sundberg M. Interindividual differences in hepatic expression of CYP3A4: relationship to genetic polymorphism in the 5'-upstream regulatory region. Biochem Biophys Res Commun. 1999 May 27; 259(1):201-5. doi: 10.1006/bbrc.1999.0752. PMID: 10334940.
Guttman Y, Nudel A, Kerem Z. Polymorphism in Cytochrome P450 3A4 Is Ethnicity Related. Front Genet. 2019;10:224. Published 2019 Mar 19. doi:10.3389/fgene.2019.00224
Wang D, Sadee W. CYP3A4 intronic SNP rs35599367 (CYP3A4*22) alters RNA splicing. Pharmacogenet Genomics 2016;26(1):40-43. doi:10.1097/FPC.0000000000000183
Elens L, Nieuweboer A, Clarke SJ, Charles KA, de Graan AJ, Haufroid V et al. CYP3A4 intron 6 C4T SNP (CYP3A4*22) encodes lower CYP3A4 activity in cancer patients, as measured with probes midazolam and erythromycin. Pharmacogenomics 2013; 14: 37–49.
Dwijaya, A., & Atmaja, M. H. S. (2022). Clinical and imaging findings of klippel-trenaunay syndrome: A case report. International Journal of Health & Medical Sciences, 5(1), 145-149. https://doi.org/10.21744/ijhms.v5n1.1860
de Jonge, H., Elens, L., de Loor, H. et al. The CYP3A4*22 C>T single nucleotide polymorphism is associated with reduced midazolam and tacrolimus clearance in stable renal allograft recipients. Pharmacogenomics J 2015; 144–152. https://doi.org/10.1038/tpj.2014.49
Kitzmiller, Joseph P.; Luzum, Jasmine A.; Baldassarre, Damiano; Krauss, Ronald M.; Medina, Marisa W. CYP3A4*22 and CYP3A5*3 are associated with increased levels of plasma simvastatin concentrations in the cholesterol and pharmacogenetics study cohort. Pharmacogenetics and Genomics 2014; 24 (10): 486-491 doi: 10.1097/FPC.0000000000000079
Rinartha, K., Suryasa, W., & Kartika, L. G. S. (2018). Comparative Analysis of String Similarity on Dynamic Query Suggestions. In 2018 Electrical Power, Electronics, Communications, Controls and Informatics Seminar (EECCIS) (pp. 399-404). IEEE.
Okubo M, Murayama N, Shimizu M, Shimada T, Guengerich FP, Yamazaki H. CYP3A4 intron 6 C4T polymorphism (CYP3A4*22) is associated with reduced CYP3A4 protein level and function in human liver microsomes. J Toxicol Sci 2013; 38: 349–354.
Yunying Shi; Yi Li; Jiangtao Tang; Junlong Zhang; Yuangao Zou; Bei Cai; Lanlan Wang . Influence of CYP3A4, CYP3A5 and MDR-1 polymorphisms on tacrolimus pharmacokinetics and early renal dysfunction in liver transplant recipients. Gene. 2013 512(2), –. doi:10.1016/j.gene.2012.10.048
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
